Status Finished Effective start/end date 1/10/22 → 30/09/24
Inflammation
Pharmacology, Toxicology and Pharmaceutical Science
100%
Receptor
Pharmacology, Toxicology and Pharmaceutical Science
100%
Systemic Lupus Erythematosus
Pharmacology, Toxicology and Pharmaceutical Science
100%
Autoimmune Disease
Pharmacology, Toxicology and Pharmaceutical Science
50%
Life Expectancy
Pharmacology, Toxicology and Pharmaceutical Science
50%
Oligonucleotide
Pharmacology, Toxicology and Pharmaceutical Science
50%
Toll Like Receptor 8
Pharmacology, Toxicology and Pharmaceutical Science
50%
Toll Like Receptor 7
Pharmacology, Toxicology and Pharmaceutical Science
50%